Lynbrook (United States)

Type: City
Name: Lynbrook (United States)
Country: United States
Latitude: 40.66
Longitude: -73.669998
population: 19,626
First reported Aug 21 2014 - Updated Aug 22 2014 - 2 reports

BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite

LYNBROOK, N.Y."These positive results are very encouraging, particularly because both patients and physicians saw a statistically significant improvement in the appearance of cellulite after CCH treatment," commented Thomas L. WegmanThe Phase 2a study ... [Published Bio-Medicine - Aug 21 2014]
First reported Aug 11 2014 - Updated Aug 12 2014 - 1 reports

BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

LYNBROOK, N.Y., Aug. 11, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Financial Services - Aug 11 2014]
First reported Aug 10 2014 - Updated Aug 10 2014 - 1 reports

Chessboard made from actual wood from the ocean liner Titanic sells for $16,385 at Philip

- A chessboard made from actual wood retrieved from the wreckage of the legendary ocean liner RMS Titanic sold for $16,385 at an auction held July 23 by Philip Weiss Auctions in Lynbrook, N.Y.LYNBROOK, N.Y. – A chessboard made from actual wood retrieved ... [Published PR inside - Aug 10 2014]
First reported Aug 09 2014 - Updated Aug 09 2014 - 1 reports

US Federal Business Opportunity: Department of the Army: Impervious Surface Evaluation

Agency: Department of the ArmyOffice: National Guard Bureau Location: 175th MSG/MSCDate you need to respond by: 20-August-2014Solicitation Number: W912K6-14-T-2035 Naics code: 541620 Management, Scientific, and Technical Consulting ServicesDescripti ... [Published ITbriefing - Aug 09 2014]
First reported Aug 08 2014 - Updated Aug 09 2014 - 2 reports

BioSpecifics Technologies Corp. Announces Initiation of Phase 2 Clinical Study of CCH for Treatment of Lipoma

LYNBROOK, N.Y."Our initiation of this Phase 2 placebo-controlled clinical trial of CCH in patients with lipoma represents another important development milestone for BioSpecifics as we further advance our pipeline and continue to uncover the vast potential ... [Published Bio-Medicine - Aug 08 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

10 Ways To Save On College Textbooks

Long gone are the days when the only place to buy college textbooks was the campus bookstore.As textbook prices have skyrocketed so, thankfully, have ways to acquire them for less than the three-figure sticker price demanded for a single book.Kyla Mace, ... [Published Business Insider - Aug 05 2014]
First reported Aug 04 2014 - Updated Aug 05 2014 - 1 reports

BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014

LYNBROOK, N.Y., Aug. 4, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ... [Published PR Newswire: Health - Aug 04 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

10 Strategies for Saving on College Textbooks

Long gone are the days when the only place to buy college textbooks was the campus bookstore. As textbook prices have skyrocketed so, thankfully, have ways to acquire them for less than the three-figure sticker price demanded for a single book.Kyla Mace, ... [Published US News & World Report - Aug 01 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014

(Date:7/21/2014)... 21, 2014  An International Trade Commission (ITC) ruling ... iCH CPAP device, Taiwanese device manufacturer APEX continues to ... RMD ) is the innovation leader and pioneer ... sleep-disordered breathing. "Our research and development ... [Published Bio-Medicine - Jul 21 2014]
First reported Jun 27 2014 - Updated Jun 27 2014 - 1 reports

BioSpecifics Technologies Corp. to Be Added to Russell 3000® Index

LYNBROOK, N.Y., June 27, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced that effective ... [Published PR Newswire: Health - Jun 27 2014]
First reported Jun 25 2014 - Updated Jun 26 2014 - 1 reports

BioSpecifics Technologies Corp. Announces Filing by Sobi for EU Approval of XIAPEX for Peyronies Disease

LYNBROOK, N.Y., June 25, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced today that ... [Published PR Newswire: Health - Jun 25 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

BioSpecifics Technologies Corp. Reports First Quarter 2014 Financial Results

LYNBROOK, N.Y., May 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, today announced its financial ... [Published PR Newswire: Health - May 08 2014]

Quotes

"These positive results are very encouraging, particularly because both patients and physicians saw a statistically significant improvement in the appearance of cellulite after CCH treatment" commented Thomas L Wegman
...a statistically significant improvement in the appearance of cellulite after CCH treatment," commented Thomas L Wegman , President of BioSpecifics. "The market for cellulite treatment is large, which makes these data very exciting for the prospective commercial success of CCH in this indication. The results also position CCH as a potential treatment for other aesthetic needs, so we are eager to see continued progress by Auxilium in initiating a subsequent Phase 2b trial of CCH in cellulite in the second quarter of 2015."
...treatment and we are very excited to see how this momentum progresses going forward," reflected Thomas L Wegman, President of BioSpecifics. "Additionally, we expect to see growth in markets outside the U S for XIAFLEX. Auxilium anticipates that marketing approval for Peyronie's disease by the EMA could be granted as early as late in the first quarter of 2015. We will also receive a $0.5 million milestone payment from Auxilium as a result of Asahi Kasei's regulatory submission to potentially expand XIAFLEX into Japan in Dupuytren's contracture. A decision is expected on this regulatory submission in mid-2015."
...Aug. 11 -- International Business Machines, Armonk, New York, has been assigned a patent (8,799,294) developed by four co-inventors for a "method for enhancing search and browsing in collaborative tagging systems through learned tag hierarchies." The co-inventors are Eric Bouillet, Englewood, New Jersey, Zhen Liu, Tarrytown, New York, Anand Ranganathan, Stamford, Connecticut, and Anton Riabov...

More Content

All (29) | News (15) | Reports (0) | Blogs (13) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
BioSpecifics Technologies Corp. Announces Posit... [Published Bio-Medicine - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published TheStreet.com - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published Stock Nod - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published Reliance Trust - Aug 21 2014]
BioSpecifics Technologies Corp. Announces Posit... [Published PR Newswire: Health - Aug 21 2014]
BioSpecifics Technologies Corp. Reports Second ... [Published TickerTech.com - Aug 11 2014]
BioSpecifics Technologies Corp. Reports Second ... [Published PR Newswire: Financial Services - Aug 11 2014]
U.S. Patents Awarded to Inventors in New Jersey... [Published Insurance News Net - Aug 11 2014]
Chessboard made from actual wood from the ocean... [Published PR inside - Aug 10 2014]
US Federal Business Opportunity: Department of ... [Published ITbriefing - Aug 09 2014]
BioSpecifics Technologies Corp. Announces Initi... [Published Bio-Medicine - Aug 08 2014]
BioSpecifics Technologies Corp. Announces Initi... [Published TickerTech.com - Aug 08 2014]
BioSpecifics Technologies Corp. Announces Initi... [Published PR Newswire: Health - Aug 08 2014]
10 Ways To Save On College Textbooks [Published Business Insider - Aug 05 2014]
BioSpecifics Technologies Corp. Announces Appoi... [Published Barchart - Aug 05 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published FinanzNachrichten.de - Aug 04 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Aug 04 2014]
10 Strategies for Saving on College Textbooks [Published US News & World Report - Aug 01 2014]
Galmed Pharmaceuticals Second Quarter 2014 Conf... [Published Bio-Medicine - Jul 21 2014]
BioSpecifics Technologies Corp. to Be Added to ... [Published PR Newswire: Health - Jun 27 2014]
BioSpecifics Technologies Corp. Announces Filin... [Published PR Newswire: Health - Jun 25 2014]
BioSpecifics Announces New Analyses of XIAFLEX ... [Published PR Newswire: Health - May 19 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - May 12 2014]
BioSpecifics Technologies Corp. Reports First Q... [Published PR Newswire: Health - May 08 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - May 01 2014]
BioSpecifics Technologies Corp. to Present at t... [Published PR Newswire: Health - Apr 02 2014]
BioSpecifics Technologies Corp. Reports Fourth ... [Published Financial Services - Mar 06 2014]
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Feb 27 2014]
BioSpecifics Technologies Corp. Announces Prese... [Published PR Newswire: General Business - Feb 19 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioSpecifics Technologies Corp. Announces Posit... [Published PR Newswire: Health - Aug 21 2014]
LYNBROOK, N.Y., Aug. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. Reports Second ... [Published PR Newswire: Financial Services - Aug 11 2014]
LYNBROOK, N.Y., Aug. 11, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. Announces Initi... [Published PR Newswire: Health - Aug 08 2014]
LYNBROOK, N.Y., Aug. 8, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. to Host Confere... [Published PR Newswire: Health - Aug 04 2014]
LYNBROOK, N.Y., Aug. 4, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. ...
BioSpecifics Technologies Corp. to Be Added to ... [Published PR Newswire: Health - Jun 27 2014]
LYNBROOK, N.Y., June 27, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S. and XIAPEX® in the EU, announced that effective ...
1 2 3

Press Releases

sort by: Date | Relevance
BioSpecifics Technologies Corp. Reports Fourth ... [Published Financial Services - Mar 06 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.